Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of Reprise Biomedical's Miro3D Wound Matrix in the Outpatient Management of Wounds and Ulcerations

NCT06939673 is registered in ClinicalTrials.gov with Reprise Biomedical, Inc. as lead sponsor.

NCT NCT06939673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06939673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of Reprise Biomedical's Miro3D Wound Matrix in the Outpatient Management of Wounds and Ulcerations
Lead sponsor
Reprise Biomedical, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
February 29, 2024
Completion date
December 31, 2025
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic wounds, diabetic foot ulcers (dfus), pressure ulcers, surgical wound dehiscence (swd), undermined and tunneling wounds, venous leg ulcers (vlus)